CloudHealth Technologies Expands Business in Europe
CloudHealth Technologies, the leader in cloud service management, today announced that it is expanding its customer base, partner list and business operations in the European region. Helping to fuel the expansion is $46 million in Series D funding, which the company secured in June. The funding round will help CloudHealth Technologies scale international operations and double the size of its global workforce.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170720005189/en/
CloudHealth Technologies Expands Business in Europe (Photo: Business Wire)
Cloud adoption in EMEA is growing steadily, with the market projected to reach €44.8 billion by the year 2020, according to Market Research & Statistics1. As enterprises turn to the cloud to build apps and manage operations, they improve productivity but, at the same time, face challenges dealing with cloud complexity and managing cost.
“It comes as no surprise that public cloud adoption is accelerating in the European market, given its reputation as a hotbed for technology innovation” said Larry Begley, CFO of CloudHealth Technologies. “Enterprises in the UK and across EMEA are using CloudHealth for visibility into their cloud resources. This allows them to cut costs, improve performance, manage risks, migrate workloads and set policies. Over the next few years, our local presence will continue to grow in order to support our global customers and partners.”
In the past twelve months, CloudHealth Technologies has grown its number of direct customers in EMEA by 72 percent. During that same period, the number of partners for the region increased by 500 percent. To support this continued growth, CloudHealth Technologies has opened offices in Amsterdam and in Tel Aviv, where it counts three of the top Israeli service providers as partners: CloudZone, DoIT and AllCloud. The company also moved to an expanded office in central London, with a local workforce that will look to double by year-end 2017.
In-region event participation will continue to be a focus. Earlier this year, local cloud leaders gathered together for a CloudHealth Connect community event in London to discuss cloud challenges and best practices related to cost management, scale, security and governance. CloudHealth Technologies also exhibited at AWS Summits in London and Tel Aviv, and participated in the Cape Town Summit with partner First Distribution. During these events, booth visitors learned about the latest platform enhancements and met with cloud management experts.
“The cloud is an incredible business enabler, but scaling it can be a challenge without proper visibility,” said Tyrone Forbes, Senior Capacity and Performance Manager, EE. “When we looked for a way to optimize our AWS environment, CloudHealth was the obvious choice. It helps us control cost and usage, as well as manage thousands of EC2 instances.”
“We’re seeing huge interest in strategic cloud services, and our mission is to help others sell these services as quickly as possible,” said Russell Warne, AWS Lead at First Distribution, a CloudHealth Technologies partner based in South Africa. “CloudHealth is simply one of the strongest levers we offer. Even a new entrant can start adding significant value to customers in an incredibly short space of time.”
CloudHealth Technologies’ list of EMEA customers includes EE, Elastera, Financial Times, Funding Circle, Telefonica, Transport for London and Randstad. CloudHealth has also added many EMEA service providers to its growing Cloud Business Accelerator Program. New partners include ACA IT-Solutions, AllCloud, ANS Group, CDW, DoIT, HeleCloud, PA Consulting, Rebura LTD, Sopra Steria, Softcat plc, Storm Reply and Taldor Cloud market.
To learn more, visit www.cloudhealthtech.com.
- Blog: Financial Times: Gamifying Cost Optimization with CloudHealth
- Case study: The Economist’s Big Move to the Cloud with Help from Cloudreach and CloudHealth
- Video: NewCloudViews -- Elastera
- Video: NewCloudViews -- Cloudreach
About CloudHealth Technologies
CloudHealth, the recognized worldwide leader in the growing Cloud Service Management industry, provides integrated reporting, recommendations and active policy management to help companies control the problems associated with “cloud chaos.” Our comprehensive platform gives enterprise companies and MSPs the ability to visualize, optimize and govern their cloud and hybrid environments. By providing analysis and deep insight into historical trends, capacity planning, resource optimization and resource automation, CloudHealth enables stakeholders ranging from C-level executives to engineers, cloud specialists, architects, IT directors and LOB managers to improve performance and drive value through their cloud ecosystems. Well-known organizations that rely on CloudHealth’s capabilities and expertise include Amtrak, Dow Jones, Acquia, and Sumo Logic, among others. Based in Boston, the company is backed by Kleiner Perkins, Meritech Capital Partners, Sapphire Ventures, Scale Venture Partners, .406 Ventures and Sigma Prime Ventures. For continuous product updates, industry news and engagement visit us at www.cloudhealthtech.com or follow us @cloudhealthtech.
1 Telecom News, April 24, 2017.
Mike O’Connell or Lisa Sorrentino, 617-502-4300
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 17:41 | Pressemelding
Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut
Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 17:00 | Pressemelding
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl
Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 15:42 | Pressemelding
Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00
Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 14:00 | Pressemelding
Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu
Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 09:07 | Pressemelding
Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha
Alps Electric to Exhibit at CES 2019 as Alps Alpine for the First Time14.12.2018 07:58 | Pressemelding
Japanese comprehensive electronic components manufacturer Alps Electric Co., Ltd. (TOKYO:6770) (Ota-ku, Tokyo; President: Toshihiro Kuriyama) will exhibit at CES 2019, to open at the Las Vegas Convention and World Trade Center in Las Vegas, Nevada, in the United States on January 8. Alps Electric will be taking part as a new company, Alps Alpine Co., Ltd., for the first time. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181213006022/en/ Alps Alpine's new touch input device for automotive (Graphic: Business Wire) At CES 2019, an exposition of cutting-edge technologies brought together from around the world, Alps Electric will present a variety of technologies in response to the major trends in automotive development referred to as “CASE”—namely connected cars, autonomous driving, sharing and services, and electric vehicles. Making its first appearance at the show as a new company following its business integration with subs